Trial Details

COMPLETED
Basic Information
Clinical ID c1077
Identifier NCT01465763
Trial Title A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Ulcerative Colitis
Interventions DRUG: tofacitinib|DRUG: Placebo
Participant Information
Sponsor Pfizer
City Mobile
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2025-04-12
Primary Completion Date 2025-05-15
Completion Date 2025-05-15